Digital Product Passports contribute to a secure and tamper-resistant system, crucial in safeguarding the integrity of pharmaceutical supply chains. The decentralized nature of blockchain ensures that the information remains immune to tampering, providing an added layer of protection against counterfeit drugs and unauthorized alterations.
Counterfeit medicines have significant and severe effects on individuals’ health, pharmaceutical companies, and healthcare systems. Some of its impacts can range from:
Health risks, loss of trust in healthcare systems, loss of revenue for manufacturers, and legal and regulatory challenges
To combat this, we at Ownify have developed a blockchain-powered system that aims to eliminate counterfeit medicines by recording and verifying every step of the pharmaceutical supply chain, from production to distribution.
Digital Product Passports emerge as a revolutionary solution in the pharmaceutical industry, introducing an advanced authentication and transparency tool. Seamlessly integrated through blockchain technology, these passports establish a secure and decentralized platform to ensure the authenticity of pharmaceutical products. Each medication is endowed with a unique identifier, often presented as a QR code or NFC tag, enabling consumers to effortlessly verify legitimacy at pharmacies.
Blockchain technology provides a secure and decentralized platform that ensures the immutability and transparency of data. It eliminates the need for intermediaries, reduces fraud, and enhances trust among all stakeholders. Additionally, blockchain offers real-time visibility into transactions, enabling businesses to make informed decisions and improve overall efficiency.